Global Covid-19 Vaccine Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Description

A COVID-19 vaccine is a hypothetical vaccine against coronavirus disease 2019 (COVID-19). Although no vaccine has completed clinical trials, there are multiple attempts in progress to develop such a vaccine.

The genetic sequence of SARS-CoV-2, the coronavirus that causes COVID-19, was published on 11 January 2020, triggering intense global R&D activity to develop a vaccine against the disease. The scale of the humanitarian and economic impact of the COVID-19 pandemic is driving evaluation of next-generation vaccine technology platforms through novel paradigms to accelerate development, and the first COVID-19 vaccine candidate entered human clinical testing with unprecedented rapidity on 16 March 2020.

The global vaccine R&D effort in response to the COVID-19 pandemic is unprecedented in terms of scale and speed. Given the imperative for speed, there is an indication that vaccine could be available under emergency use or similar protocols by early 2021. This would represent a fundamental step change from the traditional vaccine development pathway, which takes on average over 10 years, even compared with the accelerated 5-year timescale for development of the first Ebola vaccine, and will necessitate novel vaccine development paradigms involving parallel and adaptive development phases, innovative regulatory processes and scaling manufacturing capacity.

According to our (Global Info Research) latest study, the global Covid-19 Vaccine market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

North America is the largest consumption place, with a consumption market share nearly 53.8% in 2026, Europe is the second largest consumption place with the consumption market share of 24.61% in 2026.

This report is a detailed and comprehensive analysis for global Covid-19 Vaccine market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:
Global Covid-19 Vaccine market size and forecasts, in consumption value ($ Million), 2018-2029
Global Covid-19 Vaccine market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Covid-19 Vaccine market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Covid-19 Vaccine market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Covid-19 Vaccine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Covid-19 Vaccine market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Moderna, CanSino Biologicals, Inovio Pharmaceuticals, Shenzhen Geno-Immune Medical Institute and GlaxoSmithKine, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market segmentation
Covid-19 Vaccine market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
    DNA
    Non-replicating Viral Vector
    Protein Subunit
    RNA
    Others

Market segment by Application
    Adults
    Children

Market segment by players, this report covers
    Moderna
    CanSino Biologicals
    Inovio Pharmaceuticals
    Shenzhen Geno-Immune Medical Institute
    GlaxoSmithKine
    Pfizer
    Johnson＆Johnson
    Heat Biologics
    Sanofi

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Covid-19 Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Covid-19 Vaccine, with revenue, gross margin and global market share of Covid-19 Vaccine from 2018 to 2023.
Chapter 3, the Covid-19 Vaccine competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Covid-19 Vaccine market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Covid-19 Vaccine.
Chapter 13, to describe Covid-19 Vaccine research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Covid-19 Vaccine
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of Covid-19 Vaccine by Type
        1.3.1 Overview: Global Covid-19 Vaccine Market Size by Type: 2018 Versus 2022 Versus 2029
        1.3.2 Global Covid-19 Vaccine Consumption Value Market Share by Type in 2022
        1.3.3 DNA
        1.3.4 Non-replicating Viral Vector
        1.3.5 Protein Subunit
        1.3.6 RNA
        1.3.7 Others
    1.4 Global Covid-19 Vaccine Market by Application
        1.4.1 Overview: Global Covid-19 Vaccine Market Size by Application: 2018 Versus 2022 Versus 2029
        1.4.2 Adults
        1.4.3 Children
    1.5 Global Covid-19 Vaccine Market Size & Forecast
    1.6 Global Covid-19 Vaccine Market Size and Forecast by Region
        1.6.1 Global Covid-19 Vaccine Market Size by Region: 2018 VS 2022 VS 2029
        1.6.2 Global Covid-19 Vaccine Market Size by Region, (2018-2029)
        1.6.3 North America Covid-19 Vaccine Market Size and Prospect (2018-2029)
        1.6.4 Europe Covid-19 Vaccine Market Size and Prospect (2018-2029)
        1.6.5 Asia-Pacific Covid-19 Vaccine Market Size and Prospect (2018-2029)
        1.6.6 South America Covid-19 Vaccine Market Size and Prospect (2018-2029)
        1.6.7 Middle East and Africa Covid-19 Vaccine Market Size and Prospect (2018-2029)

2 Company Profiles
    2.1 Moderna
        2.1.1 Moderna Details
        2.1.2 Moderna Major Business
        2.1.3 Moderna Covid-19 Vaccine Product and Solutions
        2.1.4 Moderna Covid-19 Vaccine Revenue, Gross Margin and Market Share (2018-2023)
        2.1.5 Moderna Recent Developments and Future Plans
    2.2 CanSino Biologicals
        2.2.1 CanSino Biologicals Details
        2.2.2 CanSino Biologicals Major Business
        2.2.3 CanSino Biologicals Covid-19 Vaccine Product and Solutions
        2.2.4 CanSino Biologicals Covid-19 Vaccine Revenue, Gross Margin and Market Share (2018-2023)
        2.2.5 CanSino Biologicals Recent Developments and Future Plans
    2.3 Inovio Pharmaceuticals
        2.3.1 Inovio Pharmaceuticals Details
        2.3.2 Inovio Pharmaceuticals Major Business
        2.3.3 Inovio Pharmaceuticals Covid-19 Vaccine Product and Solutions
        2.3.4 Inovio Pharmaceuticals Covid-19 Vaccine Revenue, Gross Margin and Market Share (2018-2023)
        2.3.5 Inovio Pharmaceuticals Recent Developments and Future Plans
    2.4 Shenzhen Geno-Immune Medical Institute
        2.4.1 Shenzhen Geno-Immune Medical Institute Details
        2.4.2 Shenzhen Geno-Immune Medical Institute Major Business
        2.4.3 Shenzhen Geno-Immune Medical Institute Covid-19 Vaccine Product and Solutions
        2.4.4 Shenzhen Geno-Immune Medical Institute Covid-19 Vaccine Revenue, Gross Margin and Market Share (2018-2023)
        2.4.5 Shenzhen Geno-Immune Medical Institute Recent Developments and Future Plans
    2.5 GlaxoSmithKine
        2.5.1 GlaxoSmithKine Details
        2.5.2 GlaxoSmithKine Major Business
        2.5.3 GlaxoSmithKine Covid-19 Vaccine Product and Solutions
        2.5.4 GlaxoSmithKine Covid-19 Vaccine Revenue, Gross Margin and Market Share (2018-2023)
        2.5.5 GlaxoSmithKine Recent Developments and Future Plans
    2.6 Pfizer
        2.6.1 Pfizer Details
        2.6.2 Pfizer Major Business
        2.6.3 Pfizer Covid-19 Vaccine Product and Solutions
        2.6.4 Pfizer Covid-19 Vaccine Revenue, Gross Margin and Market Share (2018-2023)
        2.6.5 Pfizer Recent Developments and Future Plans
    2.7 Johnson＆Johnson
        2.7.1 Johnson＆Johnson Details
        2.7.2 Johnson＆Johnson Major Business
        2.7.3 Johnson＆Johnson Covid-19 Vaccine Product and Solutions
        2.7.4 Johnson＆Johnson Covid-19 Vaccine Revenue, Gross Margin and Market Share (2018-2023)
        2.7.5 Johnson＆Johnson Recent Developments and Future Plans
    2.8 Heat Biologics
        2.8.1 Heat Biologics Details
        2.8.2 Heat Biologics Major Business
        2.8.3 Heat Biologics Covid-19 Vaccine Product and Solutions
        2.8.4 Heat Biologics Covid-19 Vaccine Revenue, Gross Margin and Market Share (2018-2023)
        2.8.5 Heat Biologics Recent Developments and Future Plans
    2.9 Sanofi
        2.9.1 Sanofi Details
        2.9.2 Sanofi Major Business
        2.9.3 Sanofi Covid-19 Vaccine Product and Solutions
        2.9.4 Sanofi Covid-19 Vaccine Revenue, Gross Margin and Market Share (2018-2023)
        2.9.5 Sanofi Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Covid-19 Vaccine Revenue and Share by Players (2018-2023)
    3.2 Market Share Analysis (2022)
        3.2.1 Market Share of Covid-19 Vaccine by Company Revenue
        3.2.2 Top 3 Covid-19 Vaccine Players Market Share in 2022
        3.2.3 Top 6 Covid-19 Vaccine Players Market Share in 2022
    3.3 Covid-19 Vaccine Market: Overall Company Footprint Analysis
        3.3.1 Covid-19 Vaccine Market: Region Footprint
        3.3.2 Covid-19 Vaccine Market: Company Product Type Footprint
        3.3.3 Covid-19 Vaccine Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
    4.1 Global Covid-19 Vaccine Consumption Value and Market Share by Type (2018-2023)
    4.2 Global Covid-19 Vaccine Market Forecast by Type (2024-2029)

5 Market Size Segment by Application
    5.1 Global Covid-19 Vaccine Consumption Value Market Share by Application (2018-2023)
    5.2 Global Covid-19 Vaccine Market Forecast by Application (2024-2029)

6 North America
    6.1 North America Covid-19 Vaccine Consumption Value by Type (2018-2029)
    6.2 North America Covid-19 Vaccine Consumption Value by Application (2018-2029)
    6.3 North America Covid-19 Vaccine Market Size by Country
        6.3.1 North America Covid-19 Vaccine Consumption Value by Country (2018-2029)
        6.3.2 United States Covid-19 Vaccine Market Size and Forecast (2018-2029)
        6.3.3 Canada Covid-19 Vaccine Market Size and Forecast (2018-2029)
        6.3.4 Mexico Covid-19 Vaccine Market Size and Forecast (2018-2029)

7 Europe
    7.1 Europe Covid-19 Vaccine Consumption Value by Type (2018-2029)
    7.2 Europe Covid-19 Vaccine Consumption Value by Application (2018-2029)
    7.3 Europe Covid-19 Vaccine Market Size by Country
        7.3.1 Europe Covid-19 Vaccine Consumption Value by Country (2018-2029)
        7.3.2 Germany Covid-19 Vaccine Market Size and Forecast (2018-2029)
        7.3.3 France Covid-19 Vaccine Market Size and Forecast (2018-2029)
        7.3.4 United Kingdom Covid-19 Vaccine Market Size and Forecast (2018-2029)
        7.3.5 Russia Covid-19 Vaccine Market Size and Forecast (2018-2029)
        7.3.6 Italy Covid-19 Vaccine Market Size and Forecast (2018-2029)

8 Asia-Pacific
    8.1 Asia-Pacific Covid-19 Vaccine Consumption Value by Type (2018-2029)
    8.2 Asia-Pacific Covid-19 Vaccine Consumption Value by Application (2018-2029)
    8.3 Asia-Pacific Covid-19 Vaccine Market Size by Region
        8.3.1 Asia-Pacific Covid-19 Vaccine Consumption Value by Region (2018-2029)
        8.3.2 China Covid-19 Vaccine Market Size and Forecast (2018-2029)
        8.3.3 Japan Covid-19 Vaccine Market Size and Forecast (2018-2029)
        8.3.4 South Korea Covid-19 Vaccine Market Size and Forecast (2018-2029)
        8.3.5 India Covid-19 Vaccine Market Size and Forecast (2018-2029)
        8.3.6 Southeast Asia Covid-19 Vaccine Market Size and Forecast (2018-2029)
        8.3.7 Australia Covid-19 Vaccine Market Size and Forecast (2018-2029)

9 South America
    9.1 South America Covid-19 Vaccine Consumption Value by Type (2018-2029)
    9.2 South America Covid-19 Vaccine Consumption Value by Application (2018-2029)
    9.3 South America Covid-19 Vaccine Market Size by Country
        9.3.1 South America Covid-19 Vaccine Consumption Value by Country (2018-2029)
        9.3.2 Brazil Covid-19 Vaccine Market Size and Forecast (2018-2029)
        9.3.3 Argentina Covid-19 Vaccine Market Size and Forecast (2018-2029)

10 Middle East & Africa
    10.1 Middle East & Africa Covid-19 Vaccine Consumption Value by Type (2018-2029)
    10.2 Middle East & Africa Covid-19 Vaccine Consumption Value by Application (2018-2029)
    10.3 Middle East & Africa Covid-19 Vaccine Market Size by Country
        10.3.1 Middle East & Africa Covid-19 Vaccine Consumption Value by Country (2018-2029)
        10.3.2 Turkey Covid-19 Vaccine Market Size and Forecast (2018-2029)
        10.3.3 Saudi Arabia Covid-19 Vaccine Market Size and Forecast (2018-2029)
        10.3.4 UAE Covid-19 Vaccine Market Size and Forecast (2018-2029)

11 Market Dynamics
    11.1 Covid-19 Vaccine Market Drivers
    11.2 Covid-19 Vaccine Market Restraints
    11.3 Covid-19 Vaccine Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry
    11.5 Influence of COVID-19 and Russia-Ukraine War
        11.5.1 Influence of COVID-19
        11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis
    12.1 Covid-19 Vaccine Industry Chain
    12.2 Covid-19 Vaccine Upstream Analysis
    12.3 Covid-19 Vaccine Midstream Analysis
    12.4 Covid-19 Vaccine Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Covid-19 Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 2. Global Covid-19 Vaccine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 3. Global Covid-19 Vaccine Consumption Value by Region (2018-2023) & (USD Million)
    Table 4. Global Covid-19 Vaccine Consumption Value by Region (2024-2029) & (USD Million)
    Table 5. Moderna Company Information, Head Office, and Major Competitors
    Table 6. Moderna Major Business
    Table 7. Moderna Covid-19 Vaccine Product and Solutions
    Table 8. Moderna Covid-19 Vaccine Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 9. Moderna Recent Developments and Future Plans
    Table 10. CanSino Biologicals Company Information, Head Office, and Major Competitors
    Table 11. CanSino Biologicals Major Business
    Table 12. CanSino Biologicals Covid-19 Vaccine Product and Solutions
    Table 13. CanSino Biologicals Covid-19 Vaccine Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 14. CanSino Biologicals Recent Developments and Future Plans
    Table 15. Inovio Pharmaceuticals Company Information, Head Office, and Major Competitors
    Table 16. Inovio Pharmaceuticals Major Business
    Table 17. Inovio Pharmaceuticals Covid-19 Vaccine Product and Solutions
    Table 18. Inovio Pharmaceuticals Covid-19 Vaccine Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 19. Inovio Pharmaceuticals Recent Developments and Future Plans
    Table 20. Shenzhen Geno-Immune Medical Institute Company Information, Head Office, and Major Competitors
    Table 21. Shenzhen Geno-Immune Medical Institute Major Business
    Table 22. Shenzhen Geno-Immune Medical Institute Covid-19 Vaccine Product and Solutions
    Table 23. Shenzhen Geno-Immune Medical Institute Covid-19 Vaccine Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 24. Shenzhen Geno-Immune Medical Institute Recent Developments and Future Plans
    Table 25. GlaxoSmithKine Company Information, Head Office, and Major Competitors
    Table 26. GlaxoSmithKine Major Business
    Table 27. GlaxoSmithKine Covid-19 Vaccine Product and Solutions
    Table 28. GlaxoSmithKine Covid-19 Vaccine Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 29. GlaxoSmithKine Recent Developments and Future Plans
    Table 30. Pfizer Company Information, Head Office, and Major Competitors
    Table 31. Pfizer Major Business
    Table 32. Pfizer Covid-19 Vaccine Product and Solutions
    Table 33. Pfizer Covid-19 Vaccine Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 34. Pfizer Recent Developments and Future Plans
    Table 35. Johnson＆Johnson Company Information, Head Office, and Major Competitors
    Table 36. Johnson＆Johnson Major Business
    Table 37. Johnson＆Johnson Covid-19 Vaccine Product and Solutions
    Table 38. Johnson＆Johnson Covid-19 Vaccine Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 39. Johnson＆Johnson Recent Developments and Future Plans
    Table 40. Heat Biologics Company Information, Head Office, and Major Competitors
    Table 41. Heat Biologics Major Business
    Table 42. Heat Biologics Covid-19 Vaccine Product and Solutions
    Table 43. Heat Biologics Covid-19 Vaccine Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 44. Heat Biologics Recent Developments and Future Plans
    Table 45. Sanofi Company Information, Head Office, and Major Competitors
    Table 46. Sanofi Major Business
    Table 47. Sanofi Covid-19 Vaccine Product and Solutions
    Table 48. Sanofi Covid-19 Vaccine Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 49. Sanofi Recent Developments and Future Plans
    Table 50. Global Covid-19 Vaccine Revenue (USD Million) by Players (2018-2023)
    Table 51. Global Covid-19 Vaccine Revenue Share by Players (2018-2023)
    Table 52. Breakdown of Covid-19 Vaccine by Company Type (Tier 1, Tier 2, and Tier 3)
    Table 53. Market Position of Players in Covid-19 Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
    Table 54. Head Office of Key Covid-19 Vaccine Players
    Table 55. Covid-19 Vaccine Market: Company Product Type Footprint
    Table 56. Covid-19 Vaccine Market: Company Product Application Footprint
    Table 57. Covid-19 Vaccine New Market Entrants and Barriers to Market Entry
    Table 58. Covid-19 Vaccine Mergers, Acquisition, Agreements, and Collaborations
    Table 59. Global Covid-19 Vaccine Consumption Value (USD Million) by Type (2018-2023)
    Table 60. Global Covid-19 Vaccine Consumption Value Share by Type (2018-2023)
    Table 61. Global Covid-19 Vaccine Consumption Value Forecast by Type (2024-2029)
    Table 62. Global Covid-19 Vaccine Consumption Value by Application (2018-2023)
    Table 63. Global Covid-19 Vaccine Consumption Value Forecast by Application (2024-2029)
    Table 64. North America Covid-19 Vaccine Consumption Value by Type (2018-2023) & (USD Million)
    Table 65. North America Covid-19 Vaccine Consumption Value by Type (2024-2029) & (USD Million)
    Table 66. North America Covid-19 Vaccine Consumption Value by Application (2018-2023) & (USD Million)
    Table 67. North America Covid-19 Vaccine Consumption Value by Application (2024-2029) & (USD Million)
    Table 68. North America Covid-19 Vaccine Consumption Value by Country (2018-2023) & (USD Million)
    Table 69. North America Covid-19 Vaccine Consumption Value by Country (2024-2029) & (USD Million)
    Table 70. Europe Covid-19 Vaccine Consumption Value by Type (2018-2023) & (USD Million)
    Table 71. Europe Covid-19 Vaccine Consumption Value by Type (2024-2029) & (USD Million)
    Table 72. Europe Covid-19 Vaccine Consumption Value by Application (2018-2023) & (USD Million)
    Table 73. Europe Covid-19 Vaccine Consumption Value by Application (2024-2029) & (USD Million)
    Table 74. Europe Covid-19 Vaccine Consumption Value by Country (2018-2023) & (USD Million)
    Table 75. Europe Covid-19 Vaccine Consumption Value by Country (2024-2029) & (USD Million)
    Table 76. Asia-Pacific Covid-19 Vaccine Consumption Value by Type (2018-2023) & (USD Million)
    Table 77. Asia-Pacific Covid-19 Vaccine Consumption Value by Type (2024-2029) & (USD Million)
    Table 78. Asia-Pacific Covid-19 Vaccine Consumption Value by Application (2018-2023) & (USD Million)
    Table 79. Asia-Pacific Covid-19 Vaccine Consumption Value by Application (2024-2029) & (USD Million)
    Table 80. Asia-Pacific Covid-19 Vaccine Consumption Value by Region (2018-2023) & (USD Million)
    Table 81. Asia-Pacific Covid-19 Vaccine Consumption Value by Region (2024-2029) & (USD Million)
    Table 82. South America Covid-19 Vaccine Consumption Value by Type (2018-2023) & (USD Million)
    Table 83. South America Covid-19 Vaccine Consumption Value by Type (2024-2029) & (USD Million)
    Table 84. South America Covid-19 Vaccine Consumption Value by Application (2018-2023) & (USD Million)
    Table 85. South America Covid-19 Vaccine Consumption Value by Application (2024-2029) & (USD Million)
    Table 86. South America Covid-19 Vaccine Consumption Value by Country (2018-2023) & (USD Million)
    Table 87. South America Covid-19 Vaccine Consumption Value by Country (2024-2029) & (USD Million)
    Table 88. Middle East & Africa Covid-19 Vaccine Consumption Value by Type (2018-2023) & (USD Million)
    Table 89. Middle East & Africa Covid-19 Vaccine Consumption Value by Type (2024-2029) & (USD Million)
    Table 90. Middle East & Africa Covid-19 Vaccine Consumption Value by Application (2018-2023) & (USD Million)
    Table 91. Middle East & Africa Covid-19 Vaccine Consumption Value by Application (2024-2029) & (USD Million)
    Table 92. Middle East & Africa Covid-19 Vaccine Consumption Value by Country (2018-2023) & (USD Million)
    Table 93. Middle East & Africa Covid-19 Vaccine Consumption Value by Country (2024-2029) & (USD Million)
    Table 94. Covid-19 Vaccine Raw Material
    Table 95. Key Suppliers of Covid-19 Vaccine Raw Materials
List of Figures
    Figure 1. Covid-19 Vaccine Picture
    Figure 2. Global Covid-19 Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 3. Global Covid-19 Vaccine Consumption Value Market Share by Type in 2022
    Figure 4. DNA
    Figure 5. Non-replicating Viral Vector
    Figure 6. Protein Subunit
    Figure 7. RNA
    Figure 8. Others
    Figure 9. Global Covid-19 Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 10. Covid-19 Vaccine Consumption Value Market Share by Application in 2022
    Figure 11. Adults Picture
    Figure 12. Children Picture
    Figure 13. Global Covid-19 Vaccine Consumption Value, (USD Million): 2018 & 2022 & 2029
    Figure 14. Global Covid-19 Vaccine Consumption Value and Forecast (2018-2029) & (USD Million)
    Figure 15. Global Market Covid-19 Vaccine Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
    Figure 16. Global Covid-19 Vaccine Consumption Value Market Share by Region (2018-2029)
    Figure 17. Global Covid-19 Vaccine Consumption Value Market Share by Region in 2022
    Figure 18. North America Covid-19 Vaccine Consumption Value (2018-2029) & (USD Million)
    Figure 19. Europe Covid-19 Vaccine Consumption Value (2018-2029) & (USD Million)
    Figure 20. Asia-Pacific Covid-19 Vaccine Consumption Value (2018-2029) & (USD Million)
    Figure 21. South America Covid-19 Vaccine Consumption Value (2018-2029) & (USD Million)
    Figure 22. Middle East and Africa Covid-19 Vaccine Consumption Value (2018-2029) & (USD Million)
    Figure 23. Global Covid-19 Vaccine Revenue Share by Players in 2022
    Figure 24. Covid-19 Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
    Figure 25. Global Top 3 Players Covid-19 Vaccine Market Share in 2022
    Figure 26. Global Top 6 Players Covid-19 Vaccine Market Share in 2022
    Figure 27. Global Covid-19 Vaccine Consumption Value Share by Type (2018-2023)
    Figure 28. Global Covid-19 Vaccine Market Share Forecast by Type (2024-2029)
    Figure 29. Global Covid-19 Vaccine Consumption Value Share by Application (2018-2023)
    Figure 30. Global Covid-19 Vaccine Market Share Forecast by Application (2024-2029)
    Figure 31. North America Covid-19 Vaccine Consumption Value Market Share by Type (2018-2029)
    Figure 32. North America Covid-19 Vaccine Consumption Value Market Share by Application (2018-2029)
    Figure 33. North America Covid-19 Vaccine Consumption Value Market Share by Country (2018-2029)
    Figure 34. United States Covid-19 Vaccine Consumption Value (2018-2029) & (USD Million)
    Figure 35. Canada Covid-19 Vaccine Consumption Value (2018-2029) & (USD Million)
    Figure 36. Mexico Covid-19 Vaccine Consumption Value (2018-2029) & (USD Million)
    Figure 37. Europe Covid-19 Vaccine Consumption Value Market Share by Type (2018-2029)
    Figure 38. Europe Covid-19 Vaccine Consumption Value Market Share by Application (2018-2029)
    Figure 39. Europe Covid-19 Vaccine Consumption Value Market Share by Country (2018-2029)
    Figure 40. Germany Covid-19 Vaccine Consumption Value (2018-2029) & (USD Million)
    Figure 41. France Covid-19 Vaccine Consumption Value (2018-2029) & (USD Million)
    Figure 42. United Kingdom Covid-19 Vaccine Consumption Value (2018-2029) & (USD Million)
    Figure 43. Russia Covid-19 Vaccine Consumption Value (2018-2029) & (USD Million)
    Figure 44. Italy Covid-19 Vaccine Consumption Value (2018-2029) & (USD Million)
    Figure 45. Asia-Pacific Covid-19 Vaccine Consumption Value Market Share by Type (2018-2029)
    Figure 46. Asia-Pacific Covid-19 Vaccine Consumption Value Market Share by Application (2018-2029)
    Figure 47. Asia-Pacific Covid-19 Vaccine Consumption Value Market Share by Region (2018-2029)
    Figure 48. China Covid-19 Vaccine Consumption Value (2018-2029) & (USD Million)
    Figure 49. Japan Covid-19 Vaccine Consumption Value (2018-2029) & (USD Million)
    Figure 50. South Korea Covid-19 Vaccine Consumption Value (2018-2029) & (USD Million)
    Figure 51. India Covid-19 Vaccine Consumption Value (2018-2029) & (USD Million)
    Figure 52. Southeast Asia Covid-19 Vaccine Consumption Value (2018-2029) & (USD Million)
    Figure 53. Australia Covid-19 Vaccine Consumption Value (2018-2029) & (USD Million)
    Figure 54. South America Covid-19 Vaccine Consumption Value Market Share by Type (2018-2029)
    Figure 55. South America Covid-19 Vaccine Consumption Value Market Share by Application (2018-2029)
    Figure 56. South America Covid-19 Vaccine Consumption Value Market Share by Country (2018-2029)
    Figure 57. Brazil Covid-19 Vaccine Consumption Value (2018-2029) & (USD Million)
    Figure 58. Argentina Covid-19 Vaccine Consumption Value (2018-2029) & (USD Million)
    Figure 59. Middle East and Africa Covid-19 Vaccine Consumption Value Market Share by Type (2018-2029)
    Figure 60. Middle East and Africa Covid-19 Vaccine Consumption Value Market Share by Application (2018-2029)
    Figure 61. Middle East and Africa Covid-19 Vaccine Consumption Value Market Share by Country (2018-2029)
    Figure 62. Turkey Covid-19 Vaccine Consumption Value (2018-2029) & (USD Million)
    Figure 63. Saudi Arabia Covid-19 Vaccine Consumption Value (2018-2029) & (USD Million)
    Figure 64. UAE Covid-19 Vaccine Consumption Value (2018-2029) & (USD Million)
    Figure 65. Covid-19 Vaccine Market Drivers
    Figure 66. Covid-19 Vaccine Market Restraints
    Figure 67. Covid-19 Vaccine Market Trends
    Figure 68. Porters Five Forces Analysis
    Figure 69. Manufacturing Cost Structure Analysis of Covid-19 Vaccine in 2022
    Figure 70. Manufacturing Process Analysis of Covid-19 Vaccine
    Figure 71. Covid-19 Vaccine Industrial Chain
    Figure 72. Methodology
    Figure 73. Research Process and Data Source